Fig. 2From: Sodium-dependent glucose transporter 2 inhibitor alleviates renal lipid deposition and improves renal oxygenation levels in newly diagnosed type 2 diabetes mellitus patients: a randomized controlled trialThe improvement of metabolic data in two groups of newly diagnosed T2DM patients after treatment. A Weight B Systolic blood pressure (SBP) C Diastolic blood pressure (DBP) D Triglyceride (TG) E Total cholesterol (CHO-L) F Low density lipoprotein (LDL) G uric acid (UA) H. Serum creatinine (Scr) I Fasting blood glucose (FBG) J glycosylated hemoglobin (HbA1c) * P < 0.05,** P < 0.01Back to article page